Elicio Therapeutics ELTX
NASDAQ ELTX
$1.63 +0.02 (+1.24%)
At close: Nov 11, 2026 · 4:00 PM EST

Elicio Therapeutics (ELTX) Capital Leases (2021 - 2022)

Updated

Elicio Therapeutics' Capital Leases came in at $168,000 for Q4 2022, down 28.5% from $235,000 a year earlier and down 9.7% from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Capital Leases (2021 - 2022) Analysis & Trends

Going back to Q4 2021, Elicio Therapeutics' Capital Leases data covers 5 quarters.

  • Going back by year, Capital Leases was $235,000 in FY2021.
  • Business Quant data shows ELTX's Capital Leases at $186,000 (Q3 2022), $202,000 (Q2 2022) and $219,000 (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Elicio Therapeutics 45.57 Mn -42.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 168,000.00
Sep 30, 2022 186,000.00
Jun 30, 2022 202,000.00
Mar 31, 2022 219,000.00
Dec 31, 2021 235,000.00
API Access

Elicio Therapeutics Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=ELTX&period=max&api_key=YOUR_API_KEY